Table 4 Comparative antibacterial activity of two marjoram commercial products (MR and MI) petroleum ether extract expressed as zone of inhibition (mm).
Evaluated microorganism/sample | MR (Av ± sd) | MI (Av ± sd) | Gentamycin |
|---|---|---|---|
Gram-positive bacteria | |||
Staphylococcus aureus | N/A | N/A | 24.01 ± 0.01 |
Bacillus subtilis | 16.03 ± 0.35 | 15.91 ± 0.40 | 26.02 ± 0.03 |
Streptococcus mutants | N/A | N/A | 20.01 ± 0.02 |
Bacillus cereus | 12.97 ± 0.25 | 13.71 ± 0.40 | 24.97 ± 0.06 |
Enterococcus faecalis | 14.03 ± 0.45 | 13.97 ± 0.35 | 26.09 ± 0.01 |
Gram-negative bacteria | |||
Enterobacter cloacae | 11.60 ± 0.53 | 11.56 ± 0.50 | 27.03 ± 0.06 |
Escherichia coli | N/A | N/A | 29.90 ± 0.01 |
Salmonella typhimurium | N/A | N/A | 17.02 ± 0.03 |